The role of nitric oxide in the failing heart

Heart Failure Reviews
Walter J Paulus

Abstract

Nitric oxide (NO) has effects on contractility, energetics and gene expression of failing myocardium. Initial studies on isolated cardiomyocytes showed NO to reduce systolic shortening but intracoronary infusions of NO-donors or of NO synthase (NOS) inhibitors failed to elicit changes in baseline LV contractility indices such as LVdP/dt(max). Intracoronary infusions of NO-donors or of substance P, which releases NO from the coronary endothelium, however demonstrated NO to induce a downward displacement of the left ventricular (LV) diastolic pressure-volume relation, consistent with increased LV diastolic distensibility. In end-stage failing myocardium, the increased oxygen consumption is related to reduced NO production and in isolated cardiomyocytes, NO blunts the norepinephrine-induced expression of the fetal gene programme thereby preserving myocardial calcium homeostasis.In dilated cardiomyopathy, changed endomyocardial NOS gene expression has been reported. Because of lower endomyocardial NOS gene expression in patients with higher functional class and lower LV stroke work, increased endomyocardial NOS gene expression seems to be beneficial rather than detrimental for the failing heart. A beneficial effect of increased NOS...Continue Reading

Citations

Aug 15, 2002·Proceedings of the National Academy of Sciences of the United States of America·You-Yang ZhaoKenneth R Chien
Jun 5, 2004·Medicine and Science in Sports and Exercise·Julie BarbierFrançois Carré
Mar 21, 2006·Apoptosis : an International Journal on Programmed Cell Death·D-Y LiX L Ma
May 12, 2006·Journal of Cardiovascular Electrophysiology·Edward J F Danson, David J Paterson
Dec 8, 2017·Journal of the American Heart Association·Phillip S AdamsCecilia W Lo
Apr 27, 2002·Annals of the New York Academy of Sciences·Barry Drew, Christiaan Leeuwenburgh
Aug 5, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Thibaud DamyChristophe Heymes
Mar 8, 2007·Acta Biochimica Et Biophysica Sinica·Xiaoliang WangHuirong Liu
Jan 24, 2002·Current Opinion in Critical Care·P B MassionJ L Balligand
Feb 8, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Ling TaoXin L Ma
Sep 19, 2006·Journal of the Society for Gynecologic Investigation·Yafeng Dong, Loren P Thompson
Sep 18, 2010·Journal of Hypertension·Olga Pechanova, Fedor Simko
Nov 21, 2014·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Pallavi SolankiMarc Klapholz
May 29, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Yilong FuYi Zhun Zhu
Oct 28, 2011·Clinical and Translational Science·Asma EjazLeena Pradhan
Aug 13, 2011·Expert Reviews in Molecular Medicine·Asma EjazLeena Pradhan
Jun 24, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Walter J Paulus, Jean G F Bronzwaer
Oct 14, 2021·Clinical Science·Jennifer LeggatAntonio Vidal-Puig

❮ Previous
Next ❯

Related Concepts

Related Feeds

Athletic Heart Syndrome

Athletic heart syndrome refers to the physiological and morphological changes that occur in a human heart after repetitive strenuous physical exercise. Here is the latest research.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

American Journal of Physiology. Heart and Circulatory Physiology
Walter J Paulus, Jean G F Bronzwaer
American Journal of Physiology. Heart and Circulatory Physiology
Jean G F BronzwaerWalter J Paulus
Heart Failure Reviews
Walter J Paulus, Jean G F Bronzwaer
© 2021 Meta ULC. All rights reserved